Clinical trial

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07)…

NCT00450281 · SWOG Cancer Research Network, Other · Completed

Key facts

NCT number NCT00450281
Title S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Official title Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Lung Cancer
Intervention type Genetic, Other, Procedure
Interventions chromogenic in situ hybridization, gene expression analysis, mutation analysis, polymerase chain reaction, polymorphism analysis, fluorescent antibody technique, immunohistochemistry staining method, laboratory biomarker analysis, matrix-assisted laser desorption/ionization time of flight mass spectrometry, study of socioeconomic and demographic variables and 1 more
Enrollment 981
Start date Oct 1, 2005
Primary completion Jul 1, 2012
Completion Jul 1, 2012
First posted Mar 22, 2007
Last update posted Oct 26, 2015
Countries United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies